Active Ingredient History
Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is a primary structural component of the human brain, cerebral cortex, skin, and retina. It is given the fatty acid notation 22:6(n-3). It can be synthesized from alpha-linolenic acid or obtained directly from maternal milk, fatty fish, fish oil, or algae oil. The consumption of DHA contributes to numerous physiological benefits, including cognition. As the primary structural component of nerve cells in the brain, the function of DHA is to support neuronal conduction and to allow optimal function of neuronal membrane proteins. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Aging (Phase 2)
Alzheimer Disease (Phase 2)
Amblyopia (Phase 1/Phase 2)
Arrhythmias, Cardiac (Phase 2/Phase 3)
Bariatric Surgery (Early Phase 1)
Biological Availability (Phase 4)
Bipolar Disorder (Phase 2)
Brain (Phase 4)
Breast Neoplasms (Phase 2)
Cognition (Phase 4)
Cognition Disorders (Phase 1/Phase 2)
Cognitive Dysfunction (Phase 2)
Deficiency Diseases (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Enterocolitis, Necrotizing (Phase 2)
Fatty Liver (Early Phase 1)
Fetal Growth Retardation (Phase 3)
Healthy Volunteers (Phase 4)
Hypertriglyceridemia (Phase 4)
Malnutrition (Phase 2)
Neurosciences (Phase 4)
Pediatric Obesity (Phase 4)
Pharmacokinetics (Phase 4)
Pre-Eclampsia (Phase 3)
Pregnancy Complications (Phase 2)
Premature Birth (Phase 3)
Stillbirth (Phase 3)
Work of Breathing (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue